Alvotech (ALVO) Retained Earnings (2020 - 2026)
Alvotech's (ALVO) quarterly Retained Earnings came in at $16.2 million in Q1 2026, down 6.81% YoY from $17.4 million in Q1 2025, and up 5.66% on a QoQ basis from $15.3 million in Q4 2025.
Alvotech (ALVO) Retained Earnings (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has 7 years of Retained Earnings data on file, last reported at $16.2 million in Q1 2026.
- Quarterly Retained Earnings fell 6.81% year-over-year to $16.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.2 million (down 6.81% YoY) and the FY2025 annual result came in at $15.3 million, up 100.63% from the prior year.
- Retained Earnings improved to $16.2 million in Q1 2026, from $15.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $42.9 million in Q4 2023 to a low of -$2.4 billion in Q4 2024.
- A 5-year average of -$245.7 million and a median of $17.3 million in 2025 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2023 — Retained Earnings soared 102.89% — and 2024, when it plunged 5780.85%.
- Tracing ALVO's Retained Earnings over 5 years: stood at $30.6 million in 2022, then jumped by 40.31% to $42.9 million in 2023, then sank by 5780.85% to -$2.4 billion in 2024, then jumped by 100.63% to $15.3 million in 2025, then increased by 5.66% to $16.2 million in 2026.
- The last three Retained Earnings figures came in at $16.2 million (Q1 2026), $15.3 million (Q4 2025), and $17.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn | -2.41 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.20 Mn |
| Dec 31, 2025 | 15.33 Mn |
| Sep 30, 2025 | 17.27 Mn |
| Jun 30, 2025 | 15.63 Mn |
| Mar 31, 2025 | 17.38 Mn |
| Dec 31, 2024 | -2.44 Bn |
| Sep 30, 2024 | 16.61 Mn |
| Jun 30, 2024 | 35.63 Mn |
| Mar 31, 2024 | 38.88 Mn |
| Dec 31, 2023 | 42.91 Mn |
| Jun 30, 2023 | 38.31 Mn |
| Mar 31, 2023 | 37.77 Mn |
| Dec 31, 2022 | 30.58 Mn |
| Jun 30, 2022 | -1.33 Bn |
| Dec 31, 2021 | -1.14 Bn |
| Dec 31, 2020 | -1.04 Bn |